BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 11912167)

  • 1. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.
    Rosty C; Christa L; Kuzdzal S; Baldwin WM; Zahurak ML; Carnot F; Chan DW; Canto M; Lillemoe KD; Cameron JL; Yeo CJ; Hruban RH; Goggins M
    Cancer Res; 2002 Mar; 62(6):1868-75. PubMed ID: 11912167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein profiling in pancreatic juice for detection of intraductal papillary mucinous neoplasm of the pancreas.
    Shirai Y; Sogawa K; Yamaguchi T; Sudo K; Nakagawa A; Sakai Y; Ishihara T; Sunaga M; Nezu M; Tomonaga T; Miyazaki M; Saisho H; Nomura F
    Hepatogastroenterology; 2008; 55(86-87):1824-9. PubMed ID: 19102401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100P is an early developmental marker of pancreatic carcinogenesis.
    Ohuchida K; Mizumoto K; Egami T; Yamaguchi H; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 2006 Sep; 12(18):5411-6. PubMed ID: 17000674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis.
    Guo J; Wang W; Liao P; Lou W; Ji Y; Zhang C; Wu J; Zhang S
    Cancer Sci; 2009 Dec; 100(12):2292-301. PubMed ID: 19775290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
    Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma.
    Uno K; Azuma T; Nakajima M; Yasuda K; Hayakumo T; Mukai H; Sakai T; Kawai K
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1333-8. PubMed ID: 11129230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatitis-associated protein levels in pancreatic juice from patients with pancreatic diseases.
    Motoo Y; Watanabe H; Yamaguchi Y; Xie MJ; Mouri H; Ohtsubo K; Okai T; Wakabayashi T; Sawabu N
    Pancreatology; 2001; 1(1):43-7. PubMed ID: 12120267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of biliary amylase and Hepatocarcinoma-Intestine-Pancreas/Pancreatitis-associated Protein I (HIP/PAP-I) in diagnosing biliary malignancies.
    Chen CY; Lin XZ; Wu HC; Shiesh SC
    Clin Biochem; 2005 Jun; 38(6):520-5. PubMed ID: 15885230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma.
    Wente MN; Gaida MM; Mayer C; Michalski CW; Haag N; Giese T; Felix K; Bergmann F; Giese NA; Friess H
    Int J Oncol; 2008 Aug; 33(2):297-308. PubMed ID: 18636150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatitis-associated protein is related closely to neoplastic proliferative activity in patients with colorectal carcinoma.
    Cao G; Ma J; Zhang Y; Liu B; Li F
    Anat Rec (Hoboken); 2009 Feb; 292(2):249-53. PubMed ID: 19051257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9.
    Koopmann J; Rosenzweig CN; Zhang Z; Canto MI; Brown DA; Hunter M; Yeo C; Chan DW; Breit SN; Goggins M
    Clin Cancer Res; 2006 Jan; 12(2):442-6. PubMed ID: 16428484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples.
    Ohuchida K; Mizumoto K; Yu J; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):649-54. PubMed ID: 17416753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated urinary levels and urothelial expression of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein in patients with interstitial cystitis.
    Makino T; Kawashima H; Konishi H; Nakatani T; Kiyama H
    Urology; 2010 Apr; 75(4):933-7. PubMed ID: 19646740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC; Oh MJ; Choi SH; Bae CD
    ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology.
    Scarlett CJ; Smith RC; Saxby A; Nielsen A; Samra JS; Wilson SR; Baxter RC
    Gastroenterology; 2006 May; 130(6):1670-8. PubMed ID: 16697731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEACAM1, a novel serum biomarker for pancreatic cancer.
    Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
    Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocarcinoma-intestine-pancreas/pancreatic associated protein (HIP/PAP) is expressed and secreted by proliferating ductules as well as by hepatocarcinoma and cholangiocarcinoma cells.
    Christa L; Simon MT; Brezault-Bonnet C; Bonte E; Carnot F; Zylberberg H; Franco D; Capron F; Roskams T; Bréchot C
    Am J Pathol; 1999 Nov; 155(5):1525-33. PubMed ID: 10550309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis.
    Yuan RH; Jeng YM; Chen HL; Hsieh FJ; Yang CY; Lee PH; Hsu HC
    Clin Cancer Res; 2005 Apr; 11(7):2568-75. PubMed ID: 15814635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
    Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.